FDA acknowledged that AURORA and BEACON provided sufficient evidence that bitopertin significantly lowers PPIX and that there is a strong ...
The acquisition combines AF Group and Enstar’s complementary capabilities in property and casualty insurance, including workers’ compensation, leveraging Enstar’s balance sheet strength to support AF ...
Copyright © 2026 Insider Inc and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service ...
Copyright © 2026 Insider Inc and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service ...
Delivered record operating revenues of $5.8 billion in the fourth quarter of 2025, reaching $22.4 billion for the full ...
Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH), a leading global cruise company operating Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises, today announced that its Board of ...
New White Paper Highlights 4x Productivity Gains Over Traditional BrokersFort Lauderdale, FL, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Algorhythm ...
Q4 2025 product revenue of €240 million and FY 2025 product revenue of €684 millionQ4 2025 operating profit of €10 million and cash flow from ...
HOUSTON, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Itafos Inc. (TSX-V: IFOS) (OTCQX: ITFS) (the “Company”) today announces its preliminary, unaudited Q4 2025 operational highlights and guidance for 2026.
About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics, Inc. aims to be the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with ...
Arteris is an industry leader in flexible and configurable system IP technology. To learn more about the Arteris product portfolio visit arteris.com/products.
During the quarter ended December 31, 2025, the Company sold seven properties for gross proceeds of $12.8 million and recorded a gain of $4.0 million on the dispositions. During the year ended ...